ClinicalTrials.Veeva

Menu

18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Breast Neoplasms

Treatments

Drug: 18F-FLT

Study type

Interventional

Funder types

Other

Identifiers

NCT01713049
201001043M

Details and patient eligibility

About

The purpose: To investigate the diagnostic accuracy of 18F-FLT PET for the suspicious lesions on mammograms and ultrasound.

Full description

  1. To investigate the diagnostic accuracy of 18F-FLT PET for the suspicious lesions on mammograms and ultrasound, using the pathologic result of biopsy as gold standard, and to determine whether 18F-FLT PET can increase the specificity in breast lesion diagnosis and thus reduce the unnecessary biopsy.
  2. To evaluate whether 18F-FLT PET is a cost-effective imaging modality for breast cancer diagnosis.

Enrollment

70 estimated patients

Sex

Female

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Women aged between 20 to 80 years
  2. women who have localized findings on mammography and / or ultrasound and will receive biopsy.
  3. The lesions on the conventional imaging measure >=1cm
  4. WBC count >=3000/L, or platelet>=75,000/L
  5. Liver function, AST or ALT < 78 U/L
  6. Renal function, Creatinine < 2.0 mg/dl.The laboratory examinations should be performed within 4months before our study.

Exclusion criteria

  1. Pregnant women or who are planning to be pregnant.
  2. Known cancers in other organs.
  3. Women who are not able to cooperate with the PET/CT examination.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

70 participants in 1 patient group

18F-FLT
Other group
Description:
18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound.
Treatment:
Drug: 18F-FLT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems